skov3 cells

NSC756093 potentially inhibits GBP1:PIM1 interaction. NSC756093 can be used in ovarian cancer studies.

CCT251236 is a cell-based phenotypic high-throughput screening (HTS) chemical probe developed to screen for inhibitors of the HSF1 stress pathway.CCT251236 exhibits antimyeloma activity and inhibits HSF1.

RO-3306 is a selectivity ATP-competitive CDK1 inhibitor (Ki: 20 nM). The selectivity of RO-3306 for CDK1 is >15-fold higher than a diverse panel of human kinases.

Tubulin inhibitor 8 is an inhibitor of tubulin and various cancer cell lines and inhibits tubulin polymerisation and K562 cell growth with an IC50 of 0.73 μM and 14 nM respectively.

ATG7-IN-1 is a highly potent, selective small-molecule ATG7 inhibitor with an IC₅₀ of 62 nM. ATG7-IN-1 blocks the formation of the ATG12-ATG5 and LC3-PE conjugate system at both the cellular and in vivo levels, thereby inhibiting autophagosome formation. ATG7-IN-1 can be used in research on autophagy mechanisms.

Carboplatin (JM-8) is a cisplatin derivative, a DNA synthesis inhibitor. Carboplatin binds to DNA, inhibits replication and transcription, and induces cell death. Carboplatin has antitumor activity.

Capsaicin is an active natural component found in chili peppers and acts as a TRPV1 agonist (EC50 = 0.29 μM). It possesses multiple activities, including pain relief, antitumor, anti-inflammatory, antioxidant, and neuroprotective effects, as well as some neurotoxicity. Capsaicin can be used to establish itch models.

HP-β-CD (Hydroxypropyl betadex) is a water-soluble cyclodextrin derivative obtained by hydroxypropylation of β-cyclodextrin. HP-β-CD serves as a drug delivery carrier that enhances stability and bioavailability.

Duocarmycin TM belongs to natural products, serving as a DNA alkylating agent with sequence-selective double-stranded DNA alkylation capability, featuring high cell permeability and potent antitumor activity, for targeted therapy including drug-resistant and low-proliferative tumors.

SB-743921 hydrochloride (SB743921 HCl) is an effective inhibitor of kinesin spindle protein, KSP, (Ki =0.1 nM).

IDO1-IN-7, a potent and selective indoleamine-2,3-dioxygenase-1 (IDO1) inhibitor, exhibits high potency with an IC 50 of 6.1 nM in the cellular assay (SKOV3). Apart from its inhibitory properties, IDO1-IN-7 also demonstrates immunomodulatory effects, contributing to its potential applications in cancer research.

Nutlin-3a is the active enantiomer of Nutlin-3, an MDM2 antagonist that inhibits MDM2-p53 interaction (Ki=90 nM) and activates p53. Nutlin-3a binds preferentially to the p53-binding pocket of MDM2, leading to stabilization of p53 and activation of the p53 pathway. Nutlin-3a has antitumor activity.

Vorsetuzumab mafodotin (SGN‑75) is an auristatin-based, CD70-targeted antibody-drug conjugate (ADC), composed of the humanized monoclonal antibody Vorsetuzumab and the ADC cytotoxic molecule MMAF, and exerts antitumor effects.

4F-Docetaxel (4FDT) is a fluorinated derivative of docetaxel that exhibits significant antitumor activity against hepatocellular carcinoma (HCC) and is suitable for research on liver cancer.

Ceranib-2 (3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-4-phenyl-1H-quinolin-2-one) is an inhibitor of ceramidase with an IC50 of 28 μM in SKOV3 cells. Ceranib-2 decreases levels of sphingosine and S1P, induces cell apoptosis and exhibits anticancer activity.

Apoptosis inducer37 (Derivative 10) is an agent that induces apoptosis and exhibits anticancer properties by causing cell cycle arrest at the S-G2/M phase and promoting cell apoptosis. It significantly inhibits HCT116, SKOV3, and HepG2 cancer cells with IC50 values of 24.98 μM, 26.15 μM, and 23.09 μM, respectively. Apoptosis inducer37 demonstrates antitumor activity and can be utilized in ovarian cancer research.

HQY1428 is an orally active CDK12 inhibitor. It impedes DNA replication, causing cell cycle arrest at the G2/M phase in SKOV3 cells, and induces DNA double-strand breaks as well as apoptosis. In the SKOV3 xenograft mouse model, HQY1428 demonstrates antitumor activity. Additionally, when combined with the HER2 inhibitor Lapatinib in the NCI-N87 xenograft mouse model, HQY1428 produces a synergistic therapeutic effect.

Tubulin polymerization-IN-66 (Compound 13) inhibits colony formation and tubulin polymerization while also inducing apoptosis. It reduces cell viability in A549, A2780, SKOV3, and HCC827 cells, with IC50 values of 0.84, 0.38, 0.31, and 0.34 nM, respectively. Additionally, Tubulin polymerization-IN-66 is effective against the Paclitaxel-resistant A2780/T cancer cell line as well as its parent cell line, A2780.

Theophylline-platinum(IV) prodrug-1 is a PARP-1 inhibitor. It enhances DNA damage, ROS generation, mitochondrial dysfunction, apoptosis, and S-phase arrest in SKOV3-BRCA1-KD cells while reducing invasion and metastasis. Additionally, it exhibits strong antitumor activity in SKOV3-BRCA1-KD xenograft tumor models. This compound is used for ovarian cancer research.

BER-IN-1 is a base excision repair (BER) inhibitor that specifically targets DNA apurinic/apyrimidinic (abasic) sites. It works by disrupting the BER pathway through β-elimination and β,δ-elimination cleavage at these sites, leading to DNA double-strand breaks (DSBs). BER-IN-1 enhances the effects of the PARP inhibitor Olaparib in cancer cells with normal homologous recombination repair (HR) such as MDA-MB-231, HeLa, and SKOV3. When used in combination with Olaparib, BER-IN-1 can induce S-phase arrest and apoptosis. This compound is utilized in research on cancers, including breast, cervical, and ovarian cancers.

METTL3-IN-11 is a highly selective METTL3 inhibitor (IC50 = 45.31 nM), demonstrating greater selectivity for METTL3 over DNMT1, EZH1, MLL1, and PRMT1. It reduces m6A levels in total RNA of MOLM-13 and SKOV3 cells, inducing apoptosis and inhibiting migration. METTL3-IN-11 also decreases expression of m6A downstream target genes (c-MYC and BCL2). It is applicable in ovarian cancer and acute myeloid leukemia research.

Tubulin-IN-57 is a tubulin inhibitor and a potent antiproliferative agent that suppresses colony formation, migration, and invasion of ovarian cancer cells. It disrupts tubulin polymerization, inducing G2/M phase arrest and apoptosis (apoptosis) in SKOV3 cells. In SKOV3 xenograft tumor models, Tubulin-IN-57 demonstrates significant antitumor activity without noticeable toxicity. It is applicable for ovarian cancer research.

IDO1-IN-30 (Compound (R)-100) is a potent and highly selective inhibitor of IDO1. It exhibits an IC50 value of 4.8 nM against IDO1 in SKOV3 cells. In HepG2 cells, at a concentration of 25 µM, IDO1-IN-30 does not display significant cytotoxicity. Additionally, it eliminates inhibition of CYP450 enzymes, including 3A4, 2C9, and 2D6. This compound is suitable for research related to cancer and inflammatory diseases.

Tubulin-IN-62 is a potent tubulin inhibitor targeting the colchicine binding site. It has an IC50 of 17.2 nM in SKOV3 cells and 19.3 nM in HCC827 cells. Tubulin-IN-62 inhibits microtubule polymerization, arrests the cell cycle at the G2/M phase, and induces apoptosis. In xenograft tumor models, it demonstrates significant antitumor efficacy with good tolerability. Tubulin-IN-62 is applicable for research on ovarian cancer and non-small cell lung cancer.